TY  - GEN
AU  - Hu,Hao
AU  - Qing Lin,Wei
AU  - Zhu,Qian
AU  - Wen Yang,Xiong
AU  - Wang,Hai Dong
AU  - Kuang,Yu Kang
TI  - Is there a benefit of first- or second-line crizotinib in locally advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer? a meta-analysis
SN  - 1949-2553
PY  - 2018///0223
KW  - Adult
KW  - Anaplastic Lymphoma Kinase
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Chi-Square Distribution
KW  - Crizotinib
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - Protein Kinase Inhibitors
KW  - Pyrazoles
KW  - Pyridines
KW  - Receptor Protein-Tyrosine Kinases
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Meta-Analysis; Review
UR  - https://doi.org/10.18632/oncotarget.13191
ER  -